This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Lower-cost Weight Loss Intervention Shows Promising Results, Says Study
By News Staff
All of the study's 363 overweight and obese adult participants were placed on a low-calorie diet, prescribed increases in physical activity, and attended weekly to monthly group counseling sessions. The SBWI group was assigned to a fixed program, while counseling frequency and type and other weight loss strategies could be modified every three months for the STEP group depending on the achievement of specific weight loss goals at three-month intervals.
At the end of the study, the average weight loss was 8.1 percent, or 16.8 lbs. (7.6 kg) for the SBWI group, and STEP participants lost an average 6.9 percent of their body weight, or 13.7 lbs. (6.2 kg).
According to a JAMA release, both groups also showed significant and comparable improvements in resting heart rate, blood pressure and fitness level, but the STEP program was much less expensive.
For payers, the mean cost per participant in the STEP group was $358, compared with $494 for the SBWI group. From the participants' perspective, the gap was even wider, with STEP participants spending an average of $427 versus the $863 spent by each SBWI participant.
All told, the researchers estimated that the incremental cost-effectiveness ratio for patients in the STEP group came to $127 per 2.2 lbs. (1 kg) of weight lost versus the $409 per 2.2 lbs. (1 kg) figure logged by those in the SBWI group.
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Though Waning, H7N9 Still Poses Pandemic Potential
AUA Says No to Routine PSA Screening
AAFP Criticizes Appeal of Plan B One-Step Ruling
AAFP to Hospitals: Stop Early Elective Deliveries
AAFP, USPSTF Differ Somewhat on HIV Screening Guidance
Zoledronic Acid Confers Both Pros, Cons
ACP Issues Guidance on PSA Screening
Abbott Recalls FreeStyle InsuLinx Blood Glucose Meter
Discuss Drug Options With Women at Risk for Breast Cancer
Shingles Vaccine Effective, But Uptake Is Low
Evidence Lacking to Make Oral Cancer Screening Recommendation
Two External Guidelines Get Qualified AAFP Endorsement
USPSTF Recommends BRCA Testing for High-risk Women
Primary Care, Public Health Look for Ways to Integrate
Malfunction Prompts Glucose Meter Recall
Evidence Lacking on PAD Screening, Says USPSTF
Azithromycin Poses Arrhythmia Risk, Says FDA
Vets With PTSD Often Prescribed Inappropriate Meds
AIM-HI Offers Grants to Combat Childhood Obesity
USPSTF Says No to Low-dose Vitamin D, Calcium to Prevent Fractures
PCV13, HibMenCY Vaccine Changes Approved by ACIP
AAFP, Other Groups Release More Choosing Wisely Lists
National Office Champions Tobacco Cessation Project Successful
USPSTF Issues Draft Statement on Glaucoma Screening
Study Examines Overuse, Inappropriate Use of Health Services
Apply to Become an AAFP Vaccine Science Fellow
Study Looks to Reduce PSA Screening Risks
AAP Issues New Clinical Guidance on Type 2 Diabetes
CDC: Adult Vaccination Rates Still Too Low
Pertussis Outbreaks Declining, but Immunization Still Key
2013 Immunization Schedules Include Several Changes
FDA Warns of Liver Injury Risk With Samsca Use
FDA Approves First Recombinant Trivalent Influenza Vaccine
AAFP, USPSTF: Screen Women of Childbearing Age for Partner Violence
Breast Cancer Screening in Older Women Costly, Likely Ineffective
CDC Gives Flu Update, Urges Continued Vaccination
Aerobic Exercise Beats Resistance Training for Weight Control
